Human TFPI PharmaGenie ELISA Kit (SBRS1137)

Quantify human Tissue Factor Pathway Inhibitor using a research-grade immunoassay supplied as a complete kit for laboratory workflows. TFPI is a Kunitz-type serine protease regulator that restrains the extrinsic coagulation cascade by inhibiting factor VIIa-tissue factor and factor Xa activity, making it a marker of interest in haemostasis, thrombosis, cardiovascular disease research, and sepsis studies.

The kit from Assay Genie is configured for in vitro measurement of endogenous TFPI in diverse human sample matrices, supporting pharmacokinetic and biomarker discovery workflows. It runs on standard microplate instrumentation with a colorimetric readout and is supplied as a single-use 96-assay pack.

Reagents should be stored refrigerated and protected from light to preserve activity; allow components to equilibrate to room temperature before initiating the assay protocol. The platform is intended for research use only and serves academic laboratories, core facilities, and pharmaceutical discovery groups profiling coagulation pathways, endothelial function, or therapeutic candidates that target the tissue factor axis.

Each kit provides the essential pre-coated microplate, detection antibody, calibrators, and assay buffer needed to generate a standard curve and quantify unknown samples. Researchers can deploy it to compare TFPI levels across disease cohorts, monitor responses in cell-based models, or screen compounds that influence TFPI expression in cultured endothelial or hepatic cell lines.